{"@context": "https://schema.org", "@type": "BreadcrumbList", "itemListElement": [{"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.patentleaderboard.com/"}, {"@type": "ListItem", "position": 2, "name": "Reducing the risk of human anti-human antibodies through V gene manipulation", "item": "https://www.patentleaderboard.com/patent/8198508"}]}
Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Reducing the risk of human anti-human antibodies through V gene manipulation

Reducing the risk of human anti-human antibodies through V gene manipulation

US Patent 8198508 · Granted Jun 12, 2012

Estimated economic value: $85,770,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CD38 binding domains2025
Anti-CD38 antibodies2025
Anti-Siglec-7 antibodies having reduced effector function2024
Anti-Siglec-7 antibodies for the treatment of cancer2023
Antibodies directed to the deletion mutants of epidermal growth factor receptor 2022
Anti-CD38 antibodies2022
Anti-CD38 binding domains2022
Anti-CD47 antibodies2022
Genetic engineering of non-human animals for the production of chimeric antibodi2022
Antibodies directed to HER-3 and uses thereof2022
Genetic engineering of non-human animals for the production of chimeric antibodi2022
Genetic engineering of non-human animals for the production of chimeric antibodi2022